Table 1

Patient demographic and disease characteristics

Number of patients38
Median age (range)49 (28–68)
ECOG performance status
 010
 125
 23
Prior adjuvant chemotherapy (n)24
Hormonal therapy12
Paclitaxel as 1st-line chemotherapy for metastatic disease21
Paclitaxel as 2nd- or 3rd-line chemotherapy for metastatic disease17
Previous best response to most recent paclitaxel
 Complete response (CR)1
 Partial response (PR)4
 Stable disease (SD)11
 Progressive disease (PD)22